InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the full record of transactions filed by Jacob Gary S, 董事长兼首席执行官. Insider active across 1 company, notably OKYO Pharma Ltd. Cumulatively, 3 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €52k. Activity tracked since 19 May 2022. The latest transaction was disclosed on 21 July 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Gary S. Jacob is the Chief Executive Officer of OKYO Pharma Ltd. He leads the company with a vision focused on innovation in the pharmaceutical field, aiming to develop innovative treatments for patients.